Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Fiore

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2026
Comparing large language models for antibiotic prescribing: an updated analysis using the same clinical benchmarkAntonio Russo, Nicholas Geremia, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 9, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's responseAndrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2025
Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: new kids on the ICU block?Davide Fiore Bavaro, Giuseppe Accurso, Silvia Corcione, et al.
Infectious Diseases and Therapy|August 31, 2023
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort StudyDavide Fiore Bavaro, Roberta Papagni, Alessandra Belati, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 20, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?Andrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2024
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort studyEmanuele Rando, Federica Salvati, Flavio Sangiorgi, et al.
New Microbes and New Infections|June 1, 2026
Use of Aztreonam-avibactam for infections caused by MBL-producing <i>Enterobacterales</i>Filippo Medioli, Davide Fiore Bavaro, Valeria Cento, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2023
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort studyDavide Fiore Bavaro, Alessandra Belati, Lucia Diella, et al.
Open Forum Infectious Diseases|October 21, 2022
Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" StudyDavide Fiore Bavaro, Lucia Diella, Alessandra Belati, et al.
Clinical Drug Investigation|April 22, 2021
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial InfectionsMariacristina Poliseno, Davide Fiore Bavaro, Gaetano Brindicci, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2026
Comparing large language models for antibiotic prescribing: an updated analysis using the same clinical benchmarkAntonio Russo, Nicholas Geremia, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 9, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's responseAndrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2025
Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: new kids on the ICU block?Davide Fiore Bavaro, Giuseppe Accurso, Silvia Corcione, et al.
Infectious Diseases and Therapy|August 31, 2023
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort StudyDavide Fiore Bavaro, Roberta Papagni, Alessandra Belati, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 20, 2025
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?Andrea De Vito, Nicholas Geremia, Davide Fiore Bavaro, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2024
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort studyEmanuele Rando, Federica Salvati, Flavio Sangiorgi, et al.
New Microbes and New Infections|June 1, 2026
Use of Aztreonam-avibactam for infections caused by MBL-producing <i>Enterobacterales</i>Filippo Medioli, Davide Fiore Bavaro, Valeria Cento, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2023
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort studyDavide Fiore Bavaro, Alessandra Belati, Lucia Diella, et al.
Open Forum Infectious Diseases|October 21, 2022
Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" StudyDavide Fiore Bavaro, Lucia Diella, Alessandra Belati, et al.
Clinical Drug Investigation|April 22, 2021
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial InfectionsMariacristina Poliseno, Davide Fiore Bavaro, Gaetano Brindicci, et al.
Pageof 11